Nob Hill Therapeutics (NHT) is a respiratory-focused healthcare company that uses high dose lung delivery to change the treatment paradigm for lung-related diseases. NHT's patented Dry Powder Nebulizer platform has several technological innovations that enable it to generate highly efficient drug aerosols and deliver them effectively to the lower respiratory tract, independent of the patient's lung capacity.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
08/06/24 | $3,000,000 | Series A |
TCA Venture Group Tramway Venture Partners VIC Technology Venture Development | undisclosed |